Complement 1 Appoints Dr. Christopher Cogle as Chief Medical Officer to Lead Clinical Strategy for Innovative Cancer Lifestyle PlatformRenowned oncologist and translational researcher to spearhead medical strategy as company scales innovative lifestyle modification model
Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification PlatformEvidence-based lifestyle modification platform for oncology achieves 90%+ adherence with new dedicated CoActive Coach model, significantly improving cancer-related health outcomes.
